News
Biotech firm Revvity ( RVTY) posted first-quarter results that topped analysts' estimates. The company on Monday reported adjusted earnings of $1.01 per share on revenue of $664.76 million, above the ...
Elizabeth Holmes is still locked up in prison for defrauding investors who believed in her biotech startup company, Theranos.
1dOpinion
Live Science on MSNColossal's de-extinction campaign is built on a semantic house of cards with shoddy foundations — and the consequences are dire | Opinion"Dire wolves" created by Colossal Biosciences were pegged as "the first animals in history to be brought back from extinction ...
Vertex posted first-quarter adjusted earnings per share of $4.06, with revenue rising 3% year-over-year to $2.77 billion.
5d
Pharmaceutical Technology on MSNRegeneron buys bankrupt 23andMe for $256mThe sale brings attention back to privacy concerns as Regeneron now controls genetic data from millions of 23andMe customers.
11don MSN
Researchers at the Paul Scherrer Institute PSI have developed an AI that could open up a new, cost-effective approach to ...
Before the Trump era, many pharma and biotech firms established intellectual ... Gilead Sciences CEO Daniel O’Day - Paras Griffin/Getty Images Of course, investors aren’t going to buy ...
AI evolves beyond mere algorithms to open up new frontiers in generative AI and agentic AI, and the art of the possible is ...
Melissa Beson, 37, was last seen on the Lac du Flambeau Reservation on March 17. She is the fifth person to go missing from ...
Clinical programs on track, with two major milestones later this year, and cash position, CHF 131 million as of March 31, 2025, expected to provide funding well into 2027IND filing and initial clinica ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results